{"id":"https://openalex.org/W2033433713","doi":"https://doi.org/10.1021/jm101251q","title":"Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer","display_name":"Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer","publication_year":2010,"publication_date":"2010-12-21","ids":{"openalex":"https://openalex.org/W2033433713","doi":"https://doi.org/10.1021/jm101251q","mag":"2033433713","pmid":"https://pubmed.ncbi.nlm.nih.gov/21174434"},"language":"en","primary_location":{"id":"doi:10.1021/jm101251q","doi":"https://doi.org/10.1021/jm101251q","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm101251q","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112316914","display_name":"Fabrice Pierre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Fabrice Pierre","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112357841","display_name":"Peter C. Chua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter C. Chua","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107430119","display_name":"Sean O\u2019Brien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean E. O\u2019Brien","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038673041","display_name":"Adam Siddiqui-Jain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Siddiqui-Jain","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000142237","display_name":"Pauline Bourbon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Bourbon","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089576016","display_name":"Mustapha Haddach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mustapha Haddach","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014463867","display_name":"Jerome Michaux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerome Michaux","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021286275","display_name":"Johnny Y. Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnny Nagasawa","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073291894","display_name":"Michael K. Schwaebe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael K. Schwaebe","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058644903","display_name":"Eric Stefan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Stefan","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071751124","display_name":"Anne Vialettes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Vialettes","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112021855","display_name":"Jeffrey P. Whitten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey P. Whitten","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057707815","display_name":"Takung Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ta Kung Chen","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066979115","display_name":"Levan Darjania","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Levan Darjania","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006718653","display_name":"Ryan K. Stansfield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Stansfield","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018829106","display_name":"Kenna Lynn Anderes","orcid":"https://orcid.org/0000-0002-4515-2011","observed_orcids":["https://orcid.org/0000-0002-4515-2011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenna Anderes","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074653496","display_name":"Josh Bliesath","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josh Bliesath","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050272324","display_name":"Denis Drygin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Denis Drygin","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064010995","display_name":"Caroline Ho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Ho","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012365333","display_name":"May Omori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"May Omori","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073648232","display_name":"Chris Proffitt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Proffitt","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013106114","display_name":"Nicole Streiner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole Streiner","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043544496","display_name":"Katy Trent","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katy Trent","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024503165","display_name":"William G. Rice","orcid":"https://orcid.org/0000-0001-5705-9474","observed_orcids":["https://orcid.org/0000-0001-5705-9474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William G. Rice","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077836603","display_name":"David M. Ryckman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Ryckman","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5112316914"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":6.3403,"has_fulltext":false,"cited_by_count":306,"citation_normalized_percentile":{"value":0.97149953,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"54","issue":"2","first_page":"635","last_page":"654"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.3034999966621399,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.3034999966621399,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.2831999957561493,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.21770000457763672,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cx-4945","display_name":"CX-4945","score":0.9929999709129333},{"id":"https://openalex.org/keywords/casein-kinase-2","display_name":"casein kinase 2","score":0.8759999871253967},{"id":"https://openalex.org/keywords/ck2-inhibitors","display_name":"CK2 inhibitors","score":0.546999990940094},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8920000195503235},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7850000262260437},{"id":"https://openalex.org/keywords/molecular-modeling","display_name":"molecular modeling","score":0.45399999618530273},{"id":"https://openalex.org/keywords/cancer-drug-targets","display_name":"cancer drug targets","score":0.6129999756813049},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8531426787376404},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5652005672454834},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5389502644538879},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5235573649406433},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4302062690258026},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39228183031082153},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2961586117744446},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07909107208251953},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006860","descriptor_name":"Hydrogen Bonding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047390","descriptor_name":"Casein Kinase II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057927","descriptor_name":"Hydrophobic and Hydrophilic Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm101251q","doi":"https://doi.org/10.1021/jm101251q","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm101251q","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:21174434","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21174434","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W659587719","https://openalex.org/W1677175288","https://openalex.org/W1967173776","https://openalex.org/W1969543057","https://openalex.org/W1970574853","https://openalex.org/W1971294233","https://openalex.org/W1972361002","https://openalex.org/W1973180272","https://openalex.org/W1977710275","https://openalex.org/W1981387221","https://openalex.org/W1981665102","https://openalex.org/W1986915643","https://openalex.org/W1990617217","https://openalex.org/W1996547558","https://openalex.org/W2003858378","https://openalex.org/W2010839009","https://openalex.org/W2010911717","https://openalex.org/W2011219963","https://openalex.org/W2019467071","https://openalex.org/W2022398543","https://openalex.org/W2032566634","https://openalex.org/W2042577703","https://openalex.org/W2053545004","https://openalex.org/W2056744944","https://openalex.org/W2058002757","https://openalex.org/W2058462126","https://openalex.org/W2058739448","https://openalex.org/W2066622711","https://openalex.org/W2071907638","https://openalex.org/W2074281710","https://openalex.org/W2074631079","https://openalex.org/W2077813812","https://openalex.org/W2081681244","https://openalex.org/W2081685417","https://openalex.org/W2081723980","https://openalex.org/W2085173493","https://openalex.org/W2088938650","https://openalex.org/W2090467192","https://openalex.org/W2091297863","https://openalex.org/W2095798342","https://openalex.org/W2108347072","https://openalex.org/W2128456899","https://openalex.org/W2129381779","https://openalex.org/W2129881449","https://openalex.org/W2141033247","https://openalex.org/W2146672317","https://openalex.org/W2148990487","https://openalex.org/W2151575257","https://openalex.org/W2158041398","https://openalex.org/W2160953463","https://openalex.org/W2168759561","https://openalex.org/W2170926109","https://openalex.org/W2172033858","https://openalex.org/W2172171459","https://openalex.org/W2273462154","https://openalex.org/W2416705592","https://openalex.org/W2558586414","https://openalex.org/W2558589659"],"related_works":["https://openalex.org/W2005894923","https://openalex.org/W2095510836","https://openalex.org/W2140074237","https://openalex.org/W2170105403","https://openalex.org/W2136993685","https://openalex.org/W2027358914","https://openalex.org/W1976640963","https://openalex.org/W656388499","https://openalex.org/W2088938650","https://openalex.org/W1973718955"],"abstract_inverted_index":{"Herein":[0],"we":[1],"chronicle":[2],"the":[3,35,54,63,113,139,147],"discovery":[4,134],"of":[5,14,34,37,56,65,95,101,135,142],"CX-4945":[6],"(25n),":[7],"a":[8,28,92,99],"first-in-class,":[9],"orally":[10,123],"bioavailable":[11,124],"ATP-competitive":[12],"inhibitor":[13],"protein":[15],"kinase":[16],"CK2":[17,23,41,143],"in":[18,42,130,144],"clinical":[19],"trials":[20],"for":[21,62,75,146],"cancer.":[22,76],"has":[24],"long":[25],"been":[26],"considered":[27],"prime":[29],"cancer":[30],"drug":[31],"target":[32],"because":[33],"roles":[36],"deregulated":[38],"and":[39,45,109,128],"overexpressed":[40],"cancer-promoting":[43],"prosurvival":[44],"antiapoptotic":[46],"pathways.":[47],"These":[48],"biological":[49],"properties":[50],"as":[51,53],"well":[52],"suitability":[55],"CK2's":[57],"small":[58],"ATP":[59],"binding":[60,94],"site":[61],"design":[64],"selective":[66],"inhibitors,":[67],"led":[68],"us":[69],"to":[70,80,119],"fashion":[71],"novel":[72],"therapeutic":[73,140],"agents":[74],"The":[77,133],"optimization":[78],"leading":[79],"25n":[81,96,116,136],"(K(i)":[82],"=":[83],"0.38":[84],"nM)":[85],"was":[86,117],"guided":[87],"by":[88],"molecular":[89],"modeling,":[90],"suggesting":[91],"strong":[93],"resulting":[97],"from":[98],"combination":[100],"hydrophobic":[102],"interactions,":[103],"an":[104],"ionic":[105],"bridge":[106],"with":[107,112],"Lys68,":[108],"hydrogen":[110],"bonding":[111],"hinge":[114],"region.":[115],"found":[118],"be":[120],"highly":[121],"selective,":[122],"across":[125],"species":[126],"(20-51%)":[127],"efficacious":[129],"xenograft":[131],"models.":[132],"will":[137],"allow":[138],"targeting":[141],"humans":[145],"first":[148],"time.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":30},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":27},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":22},{"year":2013,"cited_by_count":23},{"year":2012,"cited_by_count":21}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}